Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. Total Liabilities 2008–2025
Regeneron Pharmaceuticals, Inc. annual total liabilities history from 2009 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Regeneron Pharmaceuticals, Inc. total liabilities as of December 31, 2025: 9.30B, a 10.66% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. total liabilities for 2025 were 9.30B, a 10.66% increase from 2024.
- Regeneron Pharmaceuticals, Inc. total liabilities for 2024 were 8.41B, a 18.27% increase from 2023.
- Regeneron Pharmaceuticals, Inc. total liabilities for 2023 were 7.11B, a 8.50% increase from 2022.
- Regeneron Pharmaceuticals, Inc. total liabilities for 2022 were 6.55B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Regeneron Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $9,302 |
| 2024 | $8,406 |
| 2023 | $7,107 |
| 2022 | $6,551 |
| 2021 | $6,666 |
| 2020 | $6,138 |
| 2019 | $3,716 |
| 2018 | $2,977 |
| 2017 | $2,620 |
| 2016 | $2,524 |
| 2015 | $1,954 |
| 2014 | $1,287 |
| 2013 | $999 |
| 2012 | $835 |
| 2011 | $838 |
Regeneron Pharmaceuticals Inc. Total Liabilities — FAQ
Regeneron Pharmaceuticals Inc. (REGN) total liabilities over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's total liabilities history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.